Skip to Main Content

Advertisement

Skip Nav Destination

Issues

Highlights

20th Anniversary Commentary

CCR Translations

CCR Perspectives in Drug Approval

Molecular Pathways

Reviews

Cancer Therapy: Clinical

Andres Forero-Torres; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Katherine E. Varley; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Vandana G. Abramson; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Yufeng Li; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Christos Vaklavas; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Nancy U. Lin; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Minetta C. Liu; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Hope S. Rugo; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Rita Nanda; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Anna M. Storniolo; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Tiffany A. Traina; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Sujata Patil; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Catherine H. Van Poznak; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Julie R. Nangia; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); William J. Irvin, Jr; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Helen Krontiras; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Jennifer F. De Los Santos; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Paul Haluska; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); William Grizzle; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Richard M. Myers; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Antonio C. Wolff; on behalf of the Translational Breast Cancer Research Consortium (TBCRC)
Author Choice

Personalized Medicine and Imaging

Author Choice
Costanza Paoletti; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Yufeng Li; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Maria C. Muñiz; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Kelley M. Kidwell; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Kimberly Aung; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Dafydd G. Thomas; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Martha E. Brown; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Vandana G. Abramson; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); William J. Irvin, Jr; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Nancy U. Lin; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Minetta C. Liu; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Rita Nanda; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Julie R. Nangia; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Anna M. Storniolo; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Tiffany A. Traina; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Christos Vaklavas; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Catherine H. Van Poznak; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Antonio C. Wolff; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Andres Forero-Torres; on behalf of the Translational Breast Cancer Research Consortium (TBCRC); Daniel F. Hayes; on behalf of the Translational Breast Cancer Research Consortium (TBCRC)

Cancer Therapy: Preclinical

Author Choice

Biology of Human Tumors

Close Modal

or Create an Account

Close Modal
Close Modal